PathGroup and uMETHOD Health Partner to Personalize Care for Mild Cognitive Impairment (MCI) and Early-stage Alzheimer’s Disease Patients
By Eric Quimby
NASHVILLE, Tenn., Nov. 9, 2022 /PRNewswire/ — uMETHOD Health, a health technology company specializing in precision medicine for complex diseases, announces a partnership with PathGroup, one of largest independent laboratories in the United States. uMETHOD’s AI-based care planning solution, RestoreU, pairs comprehensive testing from PathGroup with actionable treatment recommendations, aimed at lowering patient’s risk of developing Alzheimer’s and disease progression in its early stages. Read the full release.